SunRock Biopharma y Escugen han iniciado una colaboración estratégica para codesarrollar SRB123, un conjugado anticuerpo-fármaco (ADC, por sus siglas en inglés) first-in-class dirigido contra el r...
Read more
Time matters for patients in need, and new research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers ...
Read more
This week at Asphalion, they are highlighting key regulatory topics as part of their MedTech Week series. Today, they turn the spotlight on medical devices incorporating nanomaterials—a rapidly e...
Read more
GENESIS Biomed ha lanzado el programa GENESIS CEO Academy, una iniciativa formativa diseñada para preparar a los líderes del futuro en el ámbito de las ciencias de la vida. Este programa está orie...
Read more
Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project
Read more
Despite a challenging economic environment, the US continues to set the global standard in biotechnology. If your company is ready to expand into the US market, ICEX can offer you the support and advi...
Read more
The new study, conducted in animal models, describes a repressor factor that blocks brown fat activity: the ACBP protein. Under normal conditions, this protein would regulate when brown fat activity i...
Read more
El Servicio de Oncohematología Pediátrica del Hospital Universitari i Politècnic La Fe, a través del Grupo de Investigación Clínica y Traslacional en Cáncer (GICTC) del Instituto de Investigaci...
Read more
El Servicio de Pediatría del Hospital Universitario Virgen Macarena ha presentado en el último Congreso de la Sociedad Española de Neuropediatría (SEN) una investigación centrada en la prevalenci...
Read more
La hipoxia intermitente producida por las apneas del sueño altera el sistema inmunológico complicando el pronóstico de pacientes con tumores, como el cáncer de pulmón y el melanoma. Los resultado...
Read more
Expanded portfolio offerings include first-to-market product launches to support global health challenges New infectious disease research solutions to be spotlighted at ASM Microbe 2025
Read more
Aortyx, the medical device company backed by IQS-URL, has raised 13.8 million euros in Series A funding to advance its bioabsorbable aortic patch to the first clinical trials in patients within two ye...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
